Biotech

All Articles

Metsera join Amneal to lock down GLP-1 supply

.Along with very early phase 1 records now out in bush, metabolic health condition clothing Metsera ...

Rivus posts records to back up muscle-sparing excessive weight drug cases

.Rivus Pharmaceuticals has actually introduced the records behind its phase 2 weight problems win in...

BMS pays out $110M to form T-cell therapy contract, helping Best buy opportunity to develop prioritized pipeline

.Bristol Myers Squibb is actually spending Top Medication $110 thousand in advance to cultivate reag...

Generate gains one more $1B-plus Major Pharma collaboration

.Novartis has inked a package possibly worth greater than $1 billion along with Flagship-founded Gen...

Metsera GLP-1 data cut shows 7.5% weight management at 36 times

.Just recently debuted Metsera is actually unfolding some phase 1 record for its own GLP-1 receptor ...

Flagship really hopes biotechs flock to Mirai to enhance hereditary medications

.Amidst the genetic medications arms ethnicity, Crown jewel Pioneering is introducing a brand-new bu...

BioAge eyes $180M from IPO, exclusive positioning for weight problems tests

.BioAge Labs is actually eyeing all around $180 million in initial earnings coming from an IPO as we...

Merck's LAG-3 combo falls short colon cancer cells stage 3 research study

.An effort by Merck &amp Co. to unlock the microsatellite dependable (MSS) metastatic colon cancer m...

Spanish VC shuts $200M life sciences fund

.Spain-based Asabys Partners has closed a fund of 180 million euros ($ 200 thousand), amount of mone...

BioAge produces $198M coming from IPO as obesity biotech joins Nasdaq

.BioAge Labs is generating almost $200 thousand using its Nasdaq IPO this morning, along with the ea...